Annual Pharmacovigilance & Risk Management Strategies


Event description:

The Pharmacovigilance & Risk Management Strategies Conference is bringing experts and industry leaders together. This interactive and debate-driven meeting is a one-of-a-kind event, offering delegates the unique opportunity to network and benchmark with their peers in a roundtable format.

Benefits of attending:

Investigate the Current Regulations and Guidelines on USA and EU Pharmacovigilance.

Insight into Building Proactive Risk Management Strategies.

Introduce the New Guidelines on Adverse Event Reporting (AER) Requirements

Your speakers:

Averill Gordon - Director, Pharmacovigilance Walgreens
Bruce Donzanti - Head, US Drug Safety, Genentech (Member of The Roche Group)
Marcus Littman - Director, Drug Safety & Pharmacovigilance Risk Management Gilead Sciences
...and many more

Visitors

C-Level Executives, SVP’s, VP’s, Directors, and Chief Safety Officers from the
Best Pharmaceutical & Biotechnology Organizations who are Responsible for:

• Pharmacovigilance
• Drug Safety
• Risk Management
• Pharmacoepidemiology
• Drug & Product Safety
• Medical Directors
• Customer Engagement
• REMS
• Regulatory Affairs
• Signal Detection
• Clinical Safety
• Patient & Medical Safety

Exhibitors

C-Level Executives, SVP’s, VP’s, Directors, and Chief Safety Officers from the
Best Pharmaceutical & Biotechnology Organizations who are Responsible for:

• Pharmacovigilance
• Drug Safety
• Risk Management
• Pharmacoepidemiology
• Drug & Product Safety
• Medical Directors
• Customer Engagement
• REMS
• Regulatory Affairs
• Signal Detection
• Clinical Safety
• Patient & Medical Safety

Go to event website